Hill DD, Kramer JR, Chaffin KR, et al. Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Ann Hepatol. 2023;28(2):100899.



Browse A-Z
Hill DD, Kramer JR, Chaffin KR, et al. Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Ann Hepatol. 2023;28(2):100899.